Zulu
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Izindaba Izigaba
Izindaba ezifakiwe
Imiphumela Ethembisayo Yokwelashwa Kwe-CD7 CAR-T Ehlanganiswe Nokufakelwa Kwesibili Ezigulini Eziphinde Zabuyela Kamuva T-ALL/LBL

Imiphumela Ethembisayo ye-CD7 C...
Ukusebenza Kwesikhathi Eside Kwe-CD19 CAR T-Cell Therapy ekwelapheni I-Relapsed/Refractory Acute Lymphoblastic Leukemia

Ukusebenza Kwesikhathi Eside Kwe-CD19 ...
I-Bioocus Ithuthukisa I-Frontier Ekwelapheni I-Pediatric Acute Lymphoblastic Leukemia

I-Bioocus Ithuthukisa Ingaphambili...
Ukuphayona I-CAR-T Therapy ku-B-cell Acute Lymphoblastic Leukemia Ibonisa Ukusebenza Okungakaze Kubonwe

Ukuphayona kwe-CAR-T Therapy e...
Imithi Emisha Yokwelapha Yeseli ye-CAR-T Iguqula Ukwelashwa Kwezifo Ezilimazayo Zamaseli

I-CAR-T Cell Thera emisha...
Ukusebenza Okuthuthukisiwe Kwe-Antitumor Kwamaseli e-CD19 CAR-T Asekelwe ku-4-1BB ekwelapheni i-B-ALL

Ukusebenza Okuthuthukisiwe Kwe-Antitumor...
I-Lu Daopei Hospital's Low-Dose CD19 CAR-T Therapy Ibonisa Imiphumela Ethembisayo Ezigulini Ze-B-ALL

I-Low-Do yesibhedlela i-Lu Daopei...
Isu Lomgqugquzeli Unoveli Lithuthukisa Ukuphepha kanye Ukusebenza Ngempumelelo Kwe-CAR-T Therapy ku-Acute B Cell Leukemia

Isu Lophromotha Inoveli Enh...
Ucwaningo Oluyimpumelelo Lubonisa Ukuphepha kanye Ukusebenza Kokwelapha Kwe-CAR-T Ekwelapheni I-B-Cell Malignancies

I-Demonstr Yokufunda Okuthuthukile...
Intuthuko Ethuthukile Kumaseli Okubulala Wemvelo (NK) Ngaphezu kweminyaka engama-50

Intuthuko Yentuthuko eNa...
0102030405

I-ASH Voice of China| USolwazi Xian Zhang: Ukusebenza Okuphezulu Nokuphepha Kokwelashwa Kwe-Anti-BCMA CAR-T Okusekelwe Nanobody Ekwelapheni Iziguli Nge-Myeloma Ephindaphindiwe Noma Engavumelani

2024-04-09

I-ASH Voice of China.jpg

Umhlangano Waminyaka Yonke Wama-65 we-American Society of Hematology (ASH) wabanjwa kusukela mhla ziyisi-9 kuya kumhla ziyi-12 kuZibandlela wezi-2023, e-San Diego, e-USA. Njengomcimbi omkhulu wezifundo ze-hematology omkhulu kunayo yonke emhlabeni wonke, uheha izinkulungwane zochwepheshe nezifundiswa ezivela kuwo wonke umhlaba minyaka yonke ukuze babelane ngentuthuko esezingeni eliphezulu kakhulu ye-hematology kanye nedatha yomtholampilo edabukisayo. Ku-ASH Congress yalo nyaka, ucwaningo olwenziwa nguSolwazi Xian Zhang weSibhedlela iLu Dao Pei lukhethelwe ukwethula ngomlomo (Abstract No. 2107), olwaluphenya ukusebenza ngempumelelo okuphezulu nokuphepha kokwelashwa okusekelwe ku-nanobody anti-BCMA CAR-T ekwelapheni iziguli ezine i-myeloma eminingi ebuyele emuva noma ephikisayo.